We Speak Oncology

With over 200 different types of cancer and over 60 human organs in which it can occur, Oncology has a language of its own. Understanding that language requires comprehensive data and highly trained experts to interpret it.

Synovate Healthcare's Global Oncology Monitor can provide that understanding, offering gold standard data spanning all cancer types and drug therapies, from cytotoxics to biologicals to supportive care. To this, we add extensive expertise in oncology and research along with unrivalled client service. So we don't just speak oncology...

We Cover Oncology

• 2000 physicians from 10 countries across the Americas, Europe, Asia Pacific and Japan
• Regional representation in all countries
• Coverage of every practice type, small or large, in each region

We Project Oncology

• Unique annual market sizing study to ensure appropriate sample coverage
• Tried and true projection methodology

We Interpret Oncology

• Unlimited data potential: reveals patient characteristics, diagnosis, site, cell type, stage, metastases, current treatment, previous treatment, oncology adjunct product usage, adverse effects
• Extensive applications: identify potential, size the market, track progress, benchmark against competitors, understand reasons behind success / failure and design strategy, tactics and materials to help sales force achieve targets
• Unsurpassed flexibility in reporting and service: patient segments customised by definition, user-friendly database, oncology analysts, customised deliverables

We Know Oncology

• Oncology is the single largest therapy area within Synovate Healthcare
• We introduced the first oncology monitor in the US in 1991, Europe in 1998, Japan in 2001, Asia Pacific in 2006 and we're still expanding - providing unrivalled historical data
• Ad hoc work can be used in tandem with our monitor data to provide custom solutions
• We offer comprehensive oncology training to local client offices

We speak your language. Find out more by contacting Jackie Ilacqua:

Call: +1 201 529 5540 (ext. 304)
Send an email